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1  | INTRODUC TION
Chronic diseases contribute to 70-80 percent of health care costs. 
Specifically, the care of multimorbidity fails to meet the patients’ 
complex needs, leading to insufficient care. Often, this leads to acute 
and unplanned use of health care services, especially in emergency 
units, and increasing hospitalization in secondary care.
The usual goal of chronic disease management programs is to im-
prove patients’ self-management skills in increasing treatment adher-
ence, such as keeping appointments with health care professionals 
and taking prescribed medicines. Improved compliance reduces emer-
gency visits and prevents expensive hospitalization.1,2 Conventional 
disease management programs focus on the disease itself, empha-
sizing coordinated and comprehensive care pathways following 
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Abstract
Objective: To evaluate the long-term effect of telephone health coaching on health 
care and long-term care (LTC) costs in type 2 diabetes (T2D) and coronary artery 
disease (CAD) patients.
Data Sources/Study Setting: Randomized controlled trial (RCT) data were linked to 
Finnish national health and social care registries and electronic health records (EHR). 
Post-trial eight-year economic evaluation was conducted.
Study Design: A total of 1,535 patients (≥45 years) were randomized to the interven-
tion (n = 1034) and control groups (n = 501). The intervention group received monthly 
telephone health coaching for 12 months. Usual health care and LTC were provided 
for both groups.
Principal Findings: Intention-to-treat analysis showed no significant change in total 
health and long-term care costs (intervention effect €1248 [3 percent relative reduc-
tion], CI −6347 to 2217) in the intervention compared to the control group. There 
were also no significant changes among subgroups of patients with T2D or CAD.
Conclusions: Health coaching had a nonsignificant effect on health care and long-
term care costs in the 8-year follow-up among patients with T2D or CAD. More 
research is needed to study, which patient groups, at which state of the disease tra-
jectory of T2D and cardiovascular disease, would best benefit from health coaching.
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evidence-based clinical guidelines and encouraging patient compli-
ance to treatments, but they focus less on the patient’s individualized 
needs or behavior.2,3
Health coaching, a patient-centered approach aiming to em-
power patients in comanagement of their disease,4 emphasizes and 
supports patient autonomy and learning instead of compliance. It is 
based on shared decision making and collaborative goal setting facil-
itated by motivational interviewing.5-8 Based on Hale’s 8 integrative 
review, health coaching is described throughout the literature as a 
partnership between the coach and the individual. More specifically, 
it is “a goal-oriented, client-centered partnership that is health-fo-
cused and occurs through a process of client enlightenment and em-
powerment”.6 Health coaching is usually provided by certified health 
coaches or health care professionals.6 The role of the coach involves 
listening, understanding, facilitating, applauding, supporting, moti-
vating, providing feedback, and helping the patient to weigh options, 
make choices, and identify and overcome challenges in the process 
of change for better.4 Health coaching guides a learning process for 
improved disease management; therefore, if successful, it should 
lead to permanent changes in patient self-management skills and be-
havior. These changes in self-management skills and behavior take 
time to have an effect on health outcomes,10,26 and therefore, the 
impact of health coaching on health care effectiveness and cost-ef-
fectiveness should be assessed in long-term follow-ups.
Evidence on the effectiveness of health coaching is conflict-
ing, and it is based on studies with short-term follow-up only (up 
to 24 months).8-11 Due to heterogeneity of target populations and 
outcome measures, no systematic reviews with meta-analyses have 
been completed.12 Individual studies show either small significant 
effects or no effects.10 Furthermore, evidence on the cost-effec-
tiveness of health coaching remains limited: Utilization and cost of 
health care services has only been evaluated in the short term (usu-
ally 12 months), again with mixed outcomes.7,13-18 However, due to 
the nature of the underlying mechanism of change—learning rather 
than compliance—it might take longer to evidence effects. Therefore, 
long-term evaluations of the effectiveness and cost-effectiveness of 
health coaching interventions are needed.
The TERVA trial (trial registration: NCT00552903) is a health 
coaching program that was implemented in the Päijät-Häme region in 
Southern Finland and tested as a randomized controlled trial in 2007-
2009. Patients with suboptimally controlled T2D or CAD, including a 
subgroup of patients with congestive heart failure (CHF), were coached 
via telephone by trained health coaches during a one-year intervention 
period. The aim of the study was to evaluate the total health care and 
long-term care (LTC) costs among all participants and in the subgroups 
(T2D and CAD) for an 8-year follow-up of the TERVA trial.
2  | METHODS
TERVA was a prospective, longitudinal randomized controlled 
trial with three disease groups randomized into intervention and 
control groups. Recruitment of participants from the health care 
services has been described in detail previously.19 A total of 2,594 
patients who fulfilled the eligibility criteria (age 45 years or older, 
with T2D, CAD or CHF, and unmet treatment targets) were rand-
omized to either the intervention group or the control group with 
a 2:1 ratio. Of the eligible patients, 1535 (59.2 percent) gave con-
sent: 1,034 in the intervention group and 501 in the control group. 
There were no significant differences between the groups at base-
line.19 Patients with more than one disease were allocated to the 
highest morbidity disease group using the following hierarchy: 1) 
CHF, 2) CAD, and 3) T2D. T2D group criteria were medication and 
serum HbA1c > 7 percent (53 mmol/mol) without clinically evident 
cardiovascular diseases, for example, MI, stroke, or peripheral vas-
cular disease. In this article, groups 1 and 2 are combined as one, 
the CAD group.
2.1 | Usual care
In Finland, general practitioners and nurses at primary care clinics 
provide basic medical treatment, follow-up, and support for compli-
ance. Patients with T2D have 2-6 planned annual visits to a doctor or 
nurse, depending on how well the disease is under control. Primary 
health care wards provide basic care in wards for patient with less 
severe conditions who are unable to cope at home. Patients with 
complications are treated for acute needs in secondary care, either 
at outpatient clinics or as inpatients in hospitals. The CAD patients’ 
treatment planning is provided in secondary care, in addition to 1-2 
primary care visits per year. Patients in need of LTC receive home-
delivered care, care at service home facilities or nursing homes, or 
care as inpatients at primary care level. Standards for care are set 
in the Finnish Current Care Guidelines, which are independent, evi-
dence-based clinical practice guidelines.20
2.2 | Intervention
A detailed description of the health coaching intervention was 
published earlier.19 In addition to routine care as described above, 
What This Study Adds
1. Previous studies have shown mixed results on the cost-
efficiency of telephone-based health coaching with 
rather short follow-ups
2. In an 8-year follow-up of all health care and long-term 
care costs, this study found no definitive evidence for 
cost-efficiency of health coaching among type 2 diabe-
tes and coronary artery disease patients
3. Better practices for identifying patients most likely to 
benefit from health coaching should be developed
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patients in the intervention group received health coaching by tel-
ephone over 12 months.
The intervention included eight key recommendations: 1) know 
how and when to call for help; 2) learn about the condition and set 
goals; 3) take medicines correctly; 4) get recommended tests and 
services; 5) act to keep the condition well controlled; 6) make life-
style changes and reduce risks; 7) build on strengths and overcome 
obstacles; and 8) follow-up with specialists and appointments. Self-
management booklets were sent to patients to support progress to-
ward the key recommendations, and a traffic light system was used 
to visualize patients’ progress. Health coaches had access to all elec-
tronic health records (EHR) in primary and secondary care and could 
enter patient data into the EHR.
The intervention group was called by the coach 10-11 times for 
12 months. Quality control on the length, frequency, and content of 
calls was administered. The coaches were tutored individually and in 
groups throughout the intervention by a psychologist (PA) special-
izing in lifestyle change and strength-based behavioral coaching.21 
Overall intervention cost per patient was €419 per 12 months.
2.3 | Data
Data for the utilization and costs of health care and LTC were col-
lected from the beginning of the intervention (2007) to the eighth 
year of postintervention follow-up (2016) from the Finnish na-
tional registries maintained by the National Institute for Health and 
Welfare. In Finland, each citizen has a unique social security code 
enabling full linkages to the national registries providing comprehen-
sive data about each individual’s use of health care and LTC. Primary 
care data were collected from the primary health care EHR from 
2007 until 2011, after which the EHR were integrated into national 
registries (AvoHilmo) that provided data for 2012-2016. Secondary 
care data included the National Discharge Registry: the use of hos-
pital outpatient care (all types of outpatient visits) and hospital 
admissions related to diagnosis (diagnosis-related grouping, DRG). 
LTC data were collected from Care Registers for Social Welfare, and 
it includes all types of long- and short-term institutionalized care, 
housing and residential services, and home care services.
EHR data included structured data for contact types (such as 
a visit, a phone call, or electronic messaging); the patient’s age; 
the diagnosis (ICD-10); the reason for encounter (ICPC-2); and the 
employee category of the health care professional in the contact. 
Extracting the patient-level data from the patient administration 
systems (with diagnosis and contact information) made it possible 
to group each individual encounter type by the Ambulatory and 
Primary Care Related Patient Groups (APR) grouper, a grouping 
system equivalent to the DRG used in hospital care.22 The APR 
groups were supplemented with cost weights indicating the rela-
tive consumption of resources. Cost weights were based on large 
samples of time measurements in primary care contacts and proce-
dures to compile a relative value scale. All costs were deflated using 
the price index for public health care provided by Statistics Finland.
Hospitalizations and hospital outpatient visit due to any cause 
were extracted from the Hospital Discharge Register based on 
the International Classification of Diseases 10th revision (ICD-10) 
codes; the Finnish version of the Nordic Classification of Surgical 
Procedures (NCSP) codes for diagnostic and treatment procedures; 
and the respective NordDRG patient grouping classifications. The 
DRG cost weights for hospitalizations and outpatient visits were 
based on individual-level cost accounting data from several hospi-
tals. The unit cost estimates for social care encounters and bed-days 
were derived from the national price list for unit costs of health care 
services in Finland.23
2.4 | Statistical analysis
Health care and long-term care costs were assigned to each patient 
over an 8-year follow-up period, and differences in mean costs be-
tween research arms were calculated. In the assessment of statistical 
significance of differences, we used nonparametric bootstrapping. 
Bootstrapping was used to draw a sample with replacement to cal-
culate 1000 replicates of the mean difference in total costs (differ-
ence = mean costs in the intervention group – mean costs in the 
control group). Stata’s bootstrapped 95% confidence intervals were 
used to indicate uncertainty in the mean difference estimator. The 
statistical significance of the difference of mean total costs per pa-
tient between the research arms was assessed using bootstrapped t 
test. Bootstrapping is a common method to account for the non-nor-
mality typical to cost data and for potential dissimilarity in cost dis-
tributions of the compared groups.24 Intention-to-treat (ITT) strategy 
was applied, that is, all patients originally allocated to the interven-
tion and control groups were included in the analysis. To assess the 
effect of the intervention among T2D and CAD patients, subgroup 
analyses were conducted. In addition to the main ITT analysis, per-
protocol (PP) analyses were conducted excluding those of the ran-
domized patients who did not perform any activities related to the 
study after giving their consent. The cumulation of cost over time 
was assessed by drawing cumulative cost curves for each research 
arm. Statistical analyses were performed using Stata version 15.0.
3  | RESULTS
The follow-up cost data were retrieved for 1033 patients in the in-
tervention and 500 patients in the control group. One patient in each 
group was missing from the Finnish national registries, probably due 
to emigration. There were no significant differences in age and gen-
der distribution between the research arms at baseline. The average 
age of participants was 65 and 65.4 years, and the proportion of 
females was 406 (39.3 percent) and 207 (41 percent) in the interven-
tion and control groups, respectively. By the end of the eight-year 
follow-up, 26 percent (n = 269) of the patients in the intervention 
and 28 percent (n = 141) of the patients in the control group had 
become deceased.
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The cumulative cost curves per patient (Figure 1) showed that 
until a little more than two years after the beginning of the inter-
vention, the cumulative cost was higher in the intervention arm 
than in the control arm. After this, however, the difference in cu-
mulative cost changed sign, so that the cumulated cost was lower 
in the intervention arm. The difference grew steadily toward the 
end of the eight-year follow-up. The total costs accumulated per 
patient were €39 667 in the intervention group and €40 916 in the 
control group.
Figure 2 shows the mean differences in total cost per patient 
among all participants and T2D and CAD subgroups. For all par-
ticipants, the total cost of care was €1248 (3 percent) lower in the 
intervention group than in the control group. The difference was, 
however, not statistically significant (95% CI from −6374 to 2217; 
P = .20). The subgroup analysis among T2D patients showed, in av-
erage, 7 percent lower costs (€−3126), while among CAD patients, 
costs were 10 percent higher (€3543) per patient in the inter-
vention arm. Neither of these effects were, however, statistically 
significant.
To investigate where in the service system the changes in costs 
accrued, we calculated changes in the eight-year accumulated cost 
by different service types: primary care (visits and ward care), sec-
ondary care (outpatient and inpatient care), and LTC (home care, ser-
vice homes, and nursing home). Among both T2D and CAD patients, 
the analysis revealed lower costs of secondary inpatient care and 
somewhat higher home care costs in the intervention group. Effects 
on other service type costs were mixed with mostly savings for T2D 
patients and increased costs for the CAD patients (Figure 3).
In the trial, there were patients in both intervention and control 
arms, who did not perform any activities related to the study after 
their consent and allocation to the intervention or control group. 
These patients were excluded from the PP analysis, resulting in 853 
F I G U R E  1   The cumulative and annual health care and LTC (long-term care) cost per patient over 8 years of follow-up
Costs/year 1 2 3 4 5 6 7 8
ITT intervenon 2705 5983 9859 15704 21638 27204 32806 39706
ITT control 2425 5515 10091 15815 22132 28880 34702 40916
No at risk/year
ITT intervenon 1004 970 941 897 854 821 793 764











1 2 3 4 5 6 7 8Euros
Years
Annual costs intervenon Annual costs control
Cumulave costs intervenon Cumulave costs control
F I G U R E  2   Mean difference in 8-year cumulative cost per patient and bootstrapped confidence intervals. Results among all participants 
and T2D and CAD subgroups
Intervenon (N) Control (N) P-value
All paents 1033 500 -1248 (-6347-2217) 0.20
T2D sub-group 770 359 -3126 (-8288-2266) 0.18
CAD sub-group 264 142 3543 (-3629-10151) 0.79
Mean difference (bootstrapped 95% CI)
-15000 -10000 -5000 0 5000 10000 15000
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patients in the intervention and 453 patients in the control arm. The 
proportion of the deceased was 23 percent (=197) and 26 percent 
(n = 119) in the intervention and control groups, respectively.
In the PP analysis, total costs were €35 863 and €41 816 per patient 
in the intervention and control groups, respectively. Until a little more 
than two years after the beginning of the intervention, the cumulative 
cost was slightly higher in the intervention arm than in the control arm. 
After this, however, the difference in cumulative cost changed sign to 
be lower in the intervention arm. The difference grew steadily toward 
the end of the eight-year follow-up (Figure S1). A statistically signifi-
cant cost saving, €−5953 (14 percent), with a 95 percent bootstrapped 
confidence interval (CI) from €−9842 to €−1132 and P = .02 was found. 
PP analysis also showed a statistically significant cost saving of €−7287 
(17 percent) per patient due to the intervention in the T2D subgroup 
(95% CI from €−12 528 to €−1760; P = .02), but no statistically signifi-
cant effect in the CAD subgroup (Table S2).
4  | DISCUSSION
4.1 | Principal findings
We studied the eight-year cumulative health care and LTC costs of 
patients with T2D and CAD after a randomized controlled trial of a 
telephone health coaching program. At two years after the beginning 
of the intervention, the cumulative costs of the control group ex-
ceeded those of the intervention group and this difference remained 
until the end of the eight-year follow-up. However, the difference in 
the total cumulative costs per patient was not statistically significant. 
The average cost savings were greater in the T2D than in the CAD 
subgroup, but this result was neither statistically significant. Among 
both subgroups, cost savings were accrued in the secondary inpatient 
care, while effects on other health care and LTC costs were mixed.
4.2 | Comparison with other studies
To our knowledge, this study has the longest follow-up of the ef-
fects of health coaching on health care and LTC costs reported in the 
literature. Similarly, to previously reported health coaching interven-
tions,13,15-17 this intervention showed no reductions in health care 
costs in the first 12-month period.19 As there is a delay from changes 
in patients’ empowerment, learning, and behavioral changes to 
changes in physiological outcomes and following use of health ser-
vices, a long-term follow-up of costs over 8 years after the interven-
tion was conducted. In this study, after a little more than 2 years, the 
cumulative costs in the intervention group were steadily lower than 
in the control group. However, the difference in the accumulated 
8-year costs was not statistically significant.
Three issues observed in our study may explain why costs in the 
intervention group were higher during a little more than two years 
after the beginning of the intervention. First, intervention high-
lighted the adequate and enough visits to health care for optimiz-
ing care and medication. Health coaches prepared patients for visits 
with health care providers and reflected with patients after the vis-
its—building “a bridge between clinician and patient”.27
This encouragement to collaboration with health care profes-
sionals may have at first increased patients’ interest and need to 
consult their caregiver, and this might explain the increase of primary 
health care costs in the early stage of the follow-up. Second, building 
the health coaching program takes time, and the coaches keep de-
veloping their skills over the whole intervention period. In this study, 
all coaches had worked as nurses before the TERVA health coaching 
program and then trained to use the coaching methods and other 
skills required. Adaptation of new skills effectively took at least six 
months.10 Third, patients were selecting multiple behavioral goals 
over the entire 12-month intervention and it must have taken even 
longer to gradually integrate the changes into their daily lives. With 
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small but sustainable changes, clinical effects are also bound to be 
delayed.26 This is contrary to studies assigning specific lifestyle goals 
to participants and implementing strategies for compliance, which 
may produce large effects at first, but these effects tend to diminish 
significantly over time.25
4.3 | Strengths and limitations
This study has several strengths. RCT design in a real-life clinical 
setting allows the strongest evidence of potential effects of an in-
tervention in everyday clinical practice. Use of national registries 
allowed long-term follow-up of all the trial participants. The par-
ticipants in our study represented two major noncommunicable 
diseases, T2D and CAD, both among the 10 most frequent causes 
of mortality in high- and middle-income countries.28 We were able 
to conduct long-term follow-up and include the LTC costs, which 
to authors’ knowledge have not been reported in any earlier study. 
LTC, such as residential facilities, cumulates cost over long periods of 
time and therefore contributes substantially to the total cost of care. 
There were no simultaneous interventions in the region.
Limitations exist, too. We were not able to blind the participants 
nor the health care professionals treating the patients. The inter-
vention group was encouraged to be actively engaged in their treat-
ment. This may have influenced the usual care they received. In our 
experience, some health care personnel perceived the intervention 
as threatening their areas of expertise, while others found that it 
added value to their clinical practice.
In this study, we were not able to fully assess patients’ capabili-
ties to participate in the coaching intervention. The inclusion of the 
participants was solely based on clinical inclusion criteria and EHR 
review. In both groups, there were patients who gave consent but 
did not participate in any other activities related to the study, for 
example, return study questionnaires or participate in the clinical 
measurements. These patients were found to have deceased ear-
lier than those who performed at least some activities related to the 
study. Future research should attempt to define inclusion criteria 
that direct health coaching to those most potential to benefit from 
such interventions.
The intervention may have been too short for sustained effects 
to show. In the case studied, the early-stage observations and anal-
ysis on short-term 1-year follow-up showed increased cost in the 
intervention group, and the regional decision makers terminated the 
program after the one-year trial. Finally, the number of recruited pa-
tients may have been too small to observe statistically significant 
differences due to fairly large variation in individual costs. Despite 
the nonsignificant difference in cost of care, the intervention may 
still turn out to be preferable if we find marked improvements in 
long-term health outcomes.
Despite the steady improvements in diabetes care, approxi-
mately 50 percent of patients in Europe and the United States still 
do not achieve the targets of care.29,30 While health coaching has 
been suggested as a feasible means to improve chronic care and 
avoid expensive complications, evidence of its cost-efficiency is still 
lacking. Randomized controlled trials with larger numbers of patients 
and on interventions more intense or exceeding one year may be 
needed to show strong evidence for the effect of health coaching. 
Careful attention must be paid to target the program to suitable 
patient segments and to execute the health coaching intervention 
appropriately.
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